Figure 2.

The effect of rs3212855 on lung function and circulating inflammatory markers. (A) The percentage of the predicted forced expiratory volume in 1 s (FEV₁), (B) FEV₁ divided by the forced vital capacity and (C) serum C‐reactive protein levels in study participants homozygous for the major allele (n = 55) or homozygous for the minor allele together with heterozygous subjects for rs3212855. Statistical significance was tested using a Wilcoxon signed‐rank test with Bonferroni correction. *P < 0.05; **P < 0.01; ***P < 0.001.